Erythropoietin medical uses

Erythropoietins accessible for use as ameliorative agents are produced by recombinant DNA technology in corpuscle culture, and cover Epogen/Procrit (epoetin alfa) and Aranesp (darbepoetin alfa); they are acclimated in alleviative anemia consistent from abiding branch disease, anarchic bowel ache (Crohn’s ache and abscess colitis) and myelodysplasia from the analysis of blight (chemotherapy and radiation). The amalgamation inserts cover boxed warnings of added accident of death, myocardial infarction, stroke, venous thromboembolism, and bump recurrence, decidedly if acclimated to access the claret levels to added than 11 to 12 g/dl.